iPRI represents a new concept in biomedical research combining a thorough, high-level, academic approach coupled with a practical focus on providing evidence‑based information about clinical, epidemiological and prevention strategies.

iPRI aims to be inclusive rather than exclusive in terms of seeking expert opinion.

In its research activities, iPRI adheres to the highest academic standards:

  • iPRI defends high standards of epidemiological and clinical research science, with a hierarchy between studies for establishing a cause-effect relationship, i.e. consensus building between experts having no conflict of interest; systematic reviews with meta-analysis or pooled data analysis; randomized trials; observational studies; and ecological studies.
  • iPRI, with its outstanding faculty and network of international expertise, can rapidly mobilize experts to provide high-quality advice on a wide range of topics;
  • iPRI pursues the overall aim of avoidance of bias due to any agenda, political, economic or other in all its activities.

iPRI recognizes that prevention ranges from avoiding risk factors and high-risk behaviours and avoiding the development of the disease; through identifying disease at an earlier stage when effective cure is more likely, and avoiding death in patients who have developed the disease.;

Diverse, international, high-level expertise able to deliver the highest quality epidemiological and biostatistics services


All iPRI projects have an international dimension, and their results are expected to impact on clinical and preventive practices. There is a focus on health in lower‑resource countries and regions.

iPRI conducts a broad range of research projects with emphasis on prevention of chronic and infectious diseases and conditions.

Our portfolio includes the following services:

  • Prevention research: 
    • evaluation of public health programmes, screening activities, diagnostic methods and treatments’ impact on disease assessment, burden and outcome both for communicable and non-communicable diseases;
    • problem-solving approaches, aimed at establishing why certain health events occur and assessing the health and non-health consequences of human activities.
  • Epidemiological research and medical aspects of health risk assessment:
    • independent authoritative evidence and guidance on critical health risk issues, for instance: what is the evidence that a specific exposure is causally linked with a specific human health problem?
  • Clinical research:
    • technical support to authorities, companies and scientists proposing a new diagnostic intervention for preliminary studies, for improving such studies in the context of translational studies, and for conducting clinical studies leading to submission for approval by regulatory bodies;
    • international collaboration on studies through a franchise concept with selected high-quality Institutes around the world.
  • Training and education:
    • iPRI has set up a training policy for internal and external trainees through involvement in research projects. iPRI Faculty are well-known scientists with academic affiliations.
    • iPRI will engage itself in the preparation and management of training courses around the world.

Projects may include authoritative reviews and meta-analyses, secondary analyses of existing data and samples, and collection of new data and biological samples in the field. All iPRI projects result in publications in leading scientific journals.

Projects may be funded by public or private sources, as well as by iPRI itself. In all cases, sponsors have no influence in the planning, conduct, analysis or reporting of the projects.

iPRI’s research is framed within economic limitations and these must be respected so that output can be put to practical use in the real world where the research is targeted.